• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

    12/6/25 8:45:00 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABT alert in real time by email
    • University of Wisconsin wins Abbott and the Big Ten Conference's "We Give Blood" drive, awards $1 million from Abbott to advance student or community health
    • Second year of nationwide blood drive saw a 319% increase in overall participation with 83,043 donations and a 168% jump in student donors compared to 2024
    • Big Ten students, alumni, and fans helped save up to 250,000 lives during the college football season
    • A recent 'We Give Blood' survey found 92% of participants are very likely to donate again, a promising sign for building a sustainable blood supply for years to come

    ABBOTT PARK, Ill. and INDIANAPOLIS, Dec. 6, 2025 /PRNewswire/ -- Amid the nation's worst blood shortage in a generation, the University of Wisconsin rallied Big Ten students, fans and alumni to take action, winning the Abbott and the Big Ten Conference "We Give Blood" competition and inspiring 15,476 blood donations that could save up to 46,428 lives. Overall donations in the competition surged 319% compared to 2024, marking a dramatic expansion of efforts to confront the national blood shortages. In just the first 22 days of the initiative, donations surpassed last year's total as the entire Big Ten community united to strengthen the blood supply.

    University of Wisconsin won the Abbott and Big Ten

    The University of Wisconsin held off the 2024 champion, the University of Nebraska, in a close battle and will receive $1 million from Abbott to advance student or community health. Overall, the conference recorded 83,043 blood donations, which could help save up to 250,000 lives in Big Ten communities and across the country, as each donation has the potential to save up to three lives. Several schools stayed neck and neck throughout the competition, with classic rivals like The Ohio State University and the University of Michigan locked in close races.

    "This year's competition not only helped to save a record-breaking number of lives, but it also showed the power of using sports for good with all schools increasing their participation from year one," said Robert B. Ford, chairman and chief executive officer, Abbott.  "We are proud of the students, alumni, and fans who united to make a lasting impact on the blood supply, and we hope this spirit continues well beyond the season."

    Blood donations are essential in many medical situations, including for trauma patients, accident victims, cancer patients, mothers facing complications before, during, and after childbirth, and premature babies. In the U.S., someone needs blood every two seconds.

    "This life-saving partnership demonstrates the tremendous passion of the Big Ten community," said Tony Petitti, commissioner, Big Ten Conference. "We're proud to help activate our fans from coast-to-coast in support of such a valuable mission and excited for the opportunity to honor the University of Wisconsin during the 2025 Discover Big Ten Football Championship Game."

    The national blood donor pool is aging and shrinking, creating an urgent need for younger donors. Blood donations among 19- to 24-year-olds have fallen by nearly one-third in recent years. This makes college students a critical audience for the "We Give Blood" drive, and results show the message is working. Nearly 37% of student donors said the campaign inspired them to donate blood for the first time, and more than 90% reported they are likely to donate again.

    "I am incredibly proud of our Badger community for showing up with generosity, compassion, and fantastic teamwork," said Jennifer Mnookin, chancellor, University of Wisconsin-Madison. "And I'm grateful to our peers in the Big Ten for their passionate engagement in this friendly competition, and to Abbott for the opportunity. Together, we're saving lives. A huge thank you to our students, faculty, and staff and broader Badger community for demonstrating once again the power of our Wisconsin Idea commitment to public service."

    This year's competition offered people more reasons to participate:

    • Student ambassadors championed the "We Give Blood" cause at every Big Ten university, bringing together Greek life, student governments, registered student organizations, university leadership and local blood centers to have the biggest impact.
    • Abbott and the Big Ten also hosted 12 "We Give Blood" Weekly One-Up Challenges. These mini competitions tapped into collegiate rivalries, pitting two Big Ten schools against each other to see which could show up to donate the most blood during the week. In addition to saving lives, donors from the winning school received a chance to win select memorable campus experiences offered by the universities.

    The "We Give Blood" competition ran throughout the college football season, from Aug. 27 through Dec. 5. Donation totals were tracked live and the final results are available at BigTen.Org/Abbott.  

    Participants donated blood on campuses and at U.S. blood centers across the country and uploaded proof of donation to the campaign website or via text message to have their donation count for a Big Ten school. The donations received throughout the competition helped boost blood centers' supply throughout the holiday season, when donations tend to drop. 

    "The competition may be over, but the need for blood never ends," said Ford. "We encourage everyone to make blood donation a regular habit and help save lives year-round, ensuring a sustainable blood supply for years to come." 

    People can find a place to donate blood near them at BigTen.Org/Abbott.

    About the Big Ten Conference:

    The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The Big Ten Conference sponsors 28 official sports, 14 for men and 14 for women, and the broad-based programs of the 18 Big Ten institutions provide direct financial support for more than 14,000 student-athletes. For more information, visit BigTen.org.

    About Abbott:

    Abbott (NYSE:ABT) is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Connect with us at abbott.com and on LinkedIn, Facebook, Instagram, X and YouTube.

    Abbott Big Ten Logo

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/university-of-wisconsin-wins-abbott-and-big-tens-we-give-blood-competition-as-campaign-donations-surge-319-helping-save-nearly-250-000-lives-302634697.html

    SOURCE Abbott

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT

    DatePrice TargetRatingAnalyst
    10/10/2025$145.00Buy
    The Benchmark Company
    7/18/2025$145.00Hold → Buy
    Jefferies
    6/16/2025$143.00Market Perform
    Leerink Partners
    10/8/2024$130.00Outperform
    Oppenheimer
    9/19/2024$131.00Overweight
    Piper Sandler
    7/30/2024Buy → Hold
    Edward Jones
    5/30/2024$121.00Buy
    Goldman
    7/21/2023Underperform → Peer Perform
    Wolfe Research
    More analyst ratings

    $ABT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

    Lingo, Abbott's first over-the-counter biowearable, expands to Android devicesContinuous glucose monitoring devices help people maintain healthy glucose levels, which are associated with better metabolic health and lower long-term risk of chronic conditionsNew data from Lingo users highlight how protein supplementation is linked to lower glucose in people who use continuous glucose monitors, especially for people with obesity, a group at higher risk for prediabetes, type 2 diabetes and other chronic conditionsABBOTT PARK, Ill., Dec. 8, 2025 /PRNewswire/ -- Abbott (NYSE:ABT) today announced that Lingo, an over-the-counter continuous glucose monitor (CGM) and app, is now available for Android

    12/8/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

    University of Wisconsin wins Abbott and the Big Ten Conference's "We Give Blood" drive, awards $1 million from Abbott to advance student or community healthSecond year of nationwide blood drive saw a 319% increase in overall participation with 83,043 donations and a 168% jump in student donors compared to 2024Big Ten students, alumni, and fans helped save up to 250,000 lives during the college football seasonA recent 'We Give Blood' survey found 92% of participants are very likely to donate again, a promising sign for building a sustainable blood supply for years to comeABBOTT PARK, Ill. and INDIANAPOLIS, Dec. 6, 2025 /PRNewswire/ -- Amid the nation's worst blood shortage in a generation, th

    12/6/25 8:45:00 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

    Aging, nutrition and lifestyle affect muscles, especially after age 40. That's why Matt Ryan, former professional quarterback and MVP, is teaming up with Abbott to drive muscle health awareness with two new Ensure Max Protein shakesEnsure Max Protein 42g: For physically active adults, this new shake delivers 42 grams of complete protein to help build muscle tissue alongside resistance training with 23 vitamins and minerals and two key electrolytes to support muscle functionEnsure Max Protein 2 in 1 Muscle Support: For older adults who need help maintaining muscle as they age, this shake has 30 grams of protein and 1.5g of CaHMB (beta-hydroxy-beta-methylbutyrate) to help slow the breakdown of

    12/4/25 11:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Senior Vice President Shroff Eric sold $203,043 worth of Common shares without par value (1,586 units at $128.02), decreasing direct ownership by 5% to 30,384 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    11/25/25 4:17:30 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Stratton John G

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    10/2/25 5:02:53 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Roman Michael F

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    10/2/25 4:50:38 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Benchmark Company initiated coverage on Abbott Labs with a new price target

    The Benchmark Company initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $145.00

    10/10/25 8:35:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Labs upgraded by Jefferies with a new price target

    Jefferies upgraded Abbott Labs from Hold to Buy and set a new price target of $145.00

    7/18/25 7:54:43 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Leerink Partners initiated coverage on Abbott Labs with a new price target

    Leerink Partners initiated coverage of Abbott Labs with a rating of Market Perform and set a new price target of $143.00

    6/16/25 8:17:39 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    SEC Filings

    View All

    Abbott Laboratories filed SEC Form 8-K: Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Financial Statements and Exhibits

    8-K - ABBOTT LABORATORIES (0000001800) (Filer)

    11/21/25 4:06:09 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Laboratories filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - ABBOTT LABORATORIES (0000001800) (Filer)

    11/20/25 7:37:40 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Abbott Laboratories

    10-Q - ABBOTT LABORATORIES (0000001800) (Filer)

    10/29/25 4:22:25 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Leadership Updates

    Live Leadership Updates

    View All

    Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"

    Movie to feature cameos from youth who have overcome significant heart health challenges and are part of the Abbott HeartMates community as well as professional football player and HeartMates ambassador Damar Hamlin "The More the Merrier" is the first Hallmark movie ever to include cameos from real-life individuals who have overcome cardiovascular challengesCharacter in the movie was inspired by Abbott HeartMates member Zeke Mankins, who has established a friendship with Hamlin through Hamlin's ambassador role for the HeartMates communityMovie premieres on Hallmark Channel on Nov. 28, 2025, during Hallmark's Merry Thanksgiving Weekend during "Countdown to Christmas"ABBOTT PARK, Ill., Nov. 4,

    11/4/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent

    This summer, Abbott and Real Madrid are hosting tryouts across the U.S. to form the 'Abbott Dream Team'Tryout attendees will learn about health and sports nutrition, encouraging them to promote healthy habits and an active lifestyle in their communitiesEleven selected players will travel to Madrid, train at Real Madrid's world-class facilities, and be instructed by Real Madrid coachesAmerican soccer icon Clint Dempsey will mentor the athletes throughout their journeyABBOTT PARK, Ill., May 7, 2025 /PRNewswire/ -- Abbott (NYSE:ABT) announced today the creation of the inaugural 'Abbott Dream Team.' The program will seek out talented soccer players from across the United States and give them a o

    5/7/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion

    Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the appointment of Paul Wilson as Chief Commercial Officer (CCO). In this role, Mr. Wilson will lead the company's commercial strategy, overseeing sales, marketing, clinical programming, and business development initiatives. His leadership will help expand awareness, accelerate growth, and strengthen market positioning of Cagent Vascular's proprietary serration balloon technology. Mr. Wilson brings many years of experience in the medical device industry, having held senior commercial leadership positions at Teleflex (NYSE:TFX) and Abbott (NYSE:ABT). With

    3/4/25 11:38:00 AM ET
    $ABT
    $TFX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    $ABT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/13/24 4:55:58 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/9/23 10:54:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/9/22 3:15:56 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Financials

    Live finance-specific insights

    View All

    Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

    Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segmentsAcquisition will uniquely position Abbott to transform cancer care, advancing earlier detection and optimizing treatment and monitoring to help millions more people live healthier livesExact Sciences' product lines feature advanced cancer screening and diagnostic solutions, including the market-leading Cologuard® and Oncotype DX® tests, and cutting-edge liquid biopsy tests for multi-cancer early detection and molecular residual disease testingAcquisition will be immediately accretive to

    11/20/25 7:30:00 AM ET
    $ABT
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities

    Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance

    Third-quarter reported sales growth of 6.9 percent; organic sales growth of 5.5 percent or 7.5 percent excluding COVID-19 testing-related sales1Third-quarter GAAP diluted EPS of $0.94; adjusted diluted EPS of $1.30Reported operating margin of 18.1 percent of sales; adjusted operating margin of 23.0 percent, which reflects a 40 basis point increaseABBOTT PARK, Ill., Oct. 15, 2025  /PRNewswire/ -- Abbott (NYSE:ABT) today announced financial results for the third quarter ended Sept. 30, 2025. Third-quarter sales increased 6.9 percent on a reported basis, 5.5 percent on an organic basis, or 7.5 percent when excluding COVID-19 testing-related sales1.Third-quarter GAAP diluted EPS of $0.94 and ad

    10/15/25 7:30:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Hosts Conference Call for Third-Quarter Earnings

    ABBOTT PARK, Ill., Sept. 24, 2025 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at https://www.abbott.com/investors.html. An archived edition of the call will be available later that day. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in dia

    9/24/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care